RAP 0.00% 20.5¢ resapp health limited

Ann: Positive Preliminary Results from SMARTCOUGH-C-2 Study, page-34

  1. 2,702 Posts.
    lightbulb Created with Sketch. 504
    Did you happen to read this sentence???

    “Our imminent FDA, CE and TGA submissions unlock an exciting phase for ResApp as we maketangible progression towards commercialising our unique technology in multiple marketsworldw
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.